Prometheus Biosciences In...

NASDAQ: RXDX · Real-Time Price · USD
199.92
0.18 (0.09%)
At close: Jun 15, 2023, 10:00 PM

Prometheus Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Cash & Equivalents
292.42M 257.25M 54.2M
Short-Term Investments
403.33M n/a n/a
Long-Term Investments
n/a n/a n/a
Other Long-Term Assets
971K 971K 1.73M
Receivables
1.03M 1.08M 1.09M
Inventory
n/a -1.08M n/a
Other Current Assets
12.4M 8.13M n/a
Total Current Assets
708.15M 265.38M 57.46M
Property-Plant & Equipment
31.65M 1.45M 447K
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
32.62M 2.42M 2.18M
Total Assets
740.77M 267.8M 59.63M
Account Payables
762K 1.15M 958K
Deferred Revenue
1.3M 3.67M 1.88M
Short-Term Debt
3.22M 11.59M 12.35M
Other Current Liabilities
17.54M 35K 67K
Total Current Liabilities
22.82M 16.44M 15.26M
Long-Term Debt
26.32M n/a 7.4M
Other Long-Term Liabilities
41.99M n/a 129.92M
Total Long-Term Liabilities
41.99M 16.2M 141.92M
Total Liabilities
64.81M 32.65M 157.17M
Total Debt
29.54M n/a 7.4M
Common Stock
5K 4K n/a
Retained Earnings
-331.09M -189.34M -99.15M
Comprehensive Income
-429K -267.8M n/a
Shareholders Equity
675.97M 235.16M -97.54M
Total Investments
403.33M n/a n/a